Vir Biotechnology (VIR) Profit After Tax (2018 - 2025)
Historic Profit After Tax for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$163.1 million.
- Vir Biotechnology's Profit After Tax rose 2366.49% to -$163.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$499.7 million, marking a year-over-year increase of 631.69%. This contributed to the annual value of -$522.0 million for FY2024, which is 1514.46% up from last year.
- Vir Biotechnology's Profit After Tax amounted to -$163.1 million in Q3 2025, which was up 2366.49% from -$111.0 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Profit After Tax registered a high of $525.3 million during Q4 2021, and its lowest value of -$213.7 million during Q3 2024.
- Moreover, its 5-year median value for Profit After Tax was -$111.0 million (2025), whereas its average is -$25.7 million.
- As far as peak fluctuations go, Vir Biotechnology's Profit After Tax skyrocketed by 59716.89% in 2021, and later plummeted by 22374.9% in 2022.
- Vir Biotechnology's Profit After Tax (Quarter) stood at $525.3 million in 2021, then tumbled by 119.34% to -$101.6 million in 2022, then decreased by 14.14% to -$116.0 million in 2023, then increased by 9.82% to -$104.6 million in 2024, then tumbled by 55.98% to -$163.1 million in 2025.
- Its last three reported values are -$163.1 million in Q3 2025, -$111.0 million for Q2 2025, and -$121.0 million during Q1 2025.